-Hindustan Times A 2001 law protects farmers’ interests. But the seeds bill neutralises many of the enabling measures granted in it There is a draft seeds bill awaiting Parliament, which seeks to replace the old Seed Act of 1966. A law regulating seed production and trade is needed to ensure that farmers are protected against spurious seeds, and that seed producers are obliged to put only seeds of good and reliable quality...

-The Times of India NEW DELHI: The health ministry was actively mulling Compulsory Licensing, apart from price capping, of “orphan drugs” (for rare diseases), when the department of pharmaceuticals abruptly issued an order exempting such medicines from price control, derailing plans to make these drugs affordable. The health ministry discussed price capping and invoking compulsory licence for these “exorbitantly” priced “orphan drugs” at a meeting on January 3, the day when DoP...

-The Hindu New Delhi: Seed technology major Monsanto says it is suspending plans to introduce an upgraded version of its genetically modified cotton in India because of uncertainty in the “business and regulatory environment”. Activists say this is a “hypocritical” position. On July 6, Monsanto notified the Genetic Engineering Appraisal Committee, the regulatory authority for approval of biotechnology traits in India, that it was withdrawing its application for the commercial release of...

-The Hindu IPR Policy will promote indigenous knowledge on water conservation steps. The National Intellectual Property Rights (IPR) Policy will send a clear message to Washington that India’s IPR regime is not regressive, Commerce & Industry Minister Nirmala Sitharaman said. The comments come ahead of Prime Minister Narendra Modi’s visit to the U.S. next month when the issue of greater protection and enforcement of IPR may come up for discussions. Sitharaman, however, said India...

-The Hindu The policy fails to acknowledge that IP is a market-driven model’ India’s National Intellectual Property Rights (IPR) policy, unveiled on Friday, could pose a “serious” hurdle to allowing access to affordable drugs and the South Asian nation missed a chance to put in place a progressive policy, according to experts. The policy left the country’s patent laws intact and specifically did not open up Section 3(d) of the Patents Act, which...